Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: Involvement of transforming growth factor-β1

Carcinogenesis

Volumn 24, Issue 9, 2003, Pages 1435-1444

  Corallini, Alfredo ^a   Possati, Laura ^b   Trabanelli, Cecilia ^a   Giraudo, Enrico ^c   Rocchetti, Romina ^b   Talevi, Simona ^b   Caputo, Antonella ^a   Bussolino, Federico ^c   Barbanti Brodano, Giuseppe ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; RNA; TRANSFORMING GROWTH FACTOR BETA1; VIRUS T ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BK VIRUS; CANCER GROWTH; CELL DEATH; CELL IMMORTALIZATION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FIBROBLAST; GENE FUNCTION; GENE OVEREXPRESSION; HOST; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SARCOMA CELL; SEXUALLY TRANSMITTED DISEASE; STARVATION; TUMOR REGRESSION; VASCULAR TUMOR;

ANIMALS; BK VIRUS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, NUDE; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; POLYOMAVIRUS INFECTIONS; SARCOMA, KAPOSI; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR VIRUS INFECTIONS;

EID: 0141591465     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg096     Document Type: Review

References (75)

1. Roth, W.K., Brandsetter, H. and Stürzl, M. (1992) Cellular and molecular features of HIV-1-associated Kaposi's sarcoma. AIDS, 6, 895-913.
2. Peterman, T.A., Jaffe, H.W. and Beral, V. (1993) Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS, 7, 605-611.
3. Giraldo, G., Beth, E., Kourilsky, F.M., Henle, W., Miké, V., Huraux, J.M. Andersen, H.K., Gharbi, N.R., Kyalwazi, S.K. and Puissant, A. (1975) Antibody patterns to herpes-viruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int. J. Cancer, 15, 839-848.
4. McDougall, J.K., Olso, K.A., Smith, P.P. and Collier, A.C. (1987) Detection of cytomegalovirus and AIDS-associated retrovirus in tissues of patients with AIDS, Kaposi's sarcoma and persistent lymphadenopathy. Antibiot. Chemother. (Mosc.), 38, 99-112.
5. Siddiqui, A. (1983) Hepatitis B virus in Kaposi's sarcoma. Proc. Natl Acad. Sci. USA, 80, 4861-4864.
6. Huang, Y.Q., Li, J.J., Rush, M.G., Poiesz, B.J., Nicolaides, A., Jacobson, M., Zharg, W.G., Coutavas, E., Abbott, M.A. and Friedman-Kien, A.E. (1992) HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet, 339, 515-518.
7. Nickoloff, B.J., Huang, J.Q., Li, J.J. and Friedman-Kien, A.E. (1992) Immunoistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet, 339, 548-549.
8. Rappersberger, K., Tschachler, E., Zonzits, E. et al. (1990) Endemic Kaposi's sarcoma in human immunodeficiency type 1 seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J. Invest. Dermatol., 95, 371-381.
9. Barbanti-Brodano, G., Pagnani, M., Viadana, P., Beth-Giraldo, E., Giraldo, G. and Corallini, A. (1987) BK virus DNA in Kaposi's sarcoma. Antibiot. Chemother. (Mosc.), 38, 113-120.
10. Bovenzi, P., Mirandola, P., Secchiero, P., Strumia, R., Cassai, E. and Di Luca, D. (1993) Human herpesvirus 6 (variant A) in Kaposi's sarcoma. Lancet, 341, 1288-1289.
11. Chang, Y., Caserman, E., Pessin, M.S., Lee, F., Culepper, J., Knowles, D.M. and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
12. Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M.C., Sturzl, M. and Monini, P. (2001) Biology of Kaposi's sarcoma. Eur. J. Cancer, 37, 1251-1269.
13. Padgett, B.L. and Walker, D.L. (1976) New human papovavirus. Progr. Med. Virol., 22, 1-35.
14. Barbanti-Brodano, G., Martini, F., De Mattei, M., Lazzarin, L., Corallini, A. and Tognon, M. (1998) BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv. Virus Res., 50, 69-99.
15. Corallini, A., Barbanti-Brodano, G., Bortoloni, W., Nenci, I., Cassai, E., Tampieri, M., Portolani, M. and Borgatti, M. (1977) High incidence of ependymomas induced by BK virus, a human papovavirus. J. Natl Cancer Inst., 59, 1561-1564.
16. Corallini, A., Altavilla, G., Cecchetti, M.G., Fabris, G., Grossi, M.P., Balboni, P.G., Lanza, G. and Barbanti-Brodano, G. (1978) Ependymomas, malignant tumors of pancreatic islets and osteosarcomas induced in hamsters by BK virus, a human papovavirus. J. Natl Cancer Inst., 61, 875-883.
17. Corallini, A., Pagnani, M., Viadana, P. et al. (1987) Association of BK virus with human brain tumors and tumors of pancreatic islets. Int. J. Cancer, 39, 60-67.
18. Shivakumar, C.V. and Das, G.C. (1996) Interaction of human polyomavirus with the tumor-suppressor protein p53. Oncogene, 13, 323-332.
19. Dyson, N., Bernards, R., Friend, S.H., Gooding, L.R., Hassel, J.A., Major, E.O., Pipas, J.M., Vandyke, T. and Harlow, E. (1990) Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol., 64, 1353-1356.
20. Theile, M. and Grabowski, G. (1990) Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch. Virol., 113, 221-233.
21. Trabanelli, C., Corallini, A., Gruppioni, R., Sensi, A., Bonfatti, A., Campioni, D., Merlin, M., Calza, N., Possati, L. and Barbanti-Brodano, G. (1998) Chromosomal aberrations induced by BK virus T antigen in human fibroblasts. Virology, 243, 492-496.
22. Corallini, A., Pagnani, M., Viadana, P., Camellin, P., Caputo, A., Reschiglian, P., Rossi, S., Altavilla, G., Selvatici, R. and Barbanti-Brodano, G. (1987) Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region gene and the activated human c-Harvey ras oncogene. Cancer Res., 47, 6671-6677.
23. Monini, P., Rotola,. A, De Lellis, L., Corallini, A., Secchiero, P., Albini, A., Benelli, R., Parravicini, C., Barbanti-Brodano, G. and Cassai, E. (1996) Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int. J. Cancer, 66, 717-722.
24. O'Connell, K., Landman, G., Farmer, E. and Edidin, M. (1991) Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcoma like tumors in nude mice. Am. J. Pathol., 139, 743-749.
25. Bussolino, F., De Rossi, M., Sica, A., Colotta, F., Wang, J.M., Bocchietto, E., Padura, I.M., Bosia, A., Dejana, E. and Mantovani, A. (1991) Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J. Immunol., 147, 2122-2129.
26. Williams, R.L., Risau, W., Zerwes, H.G., Aguzzi, A. and Wagner, F.E. (1989) Endothelioma cells expressing the Polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell, 57, 1053-1063.
27. Drolet, B.A., Esterly, N.B. and Frieden, I.J. (1999) Hemangiomas in children. N. Engl J. Med., 341, 173-181.
28. Vecchi, A., Garlanda, C., Lampugnani, M.G. et al. (1994) Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell. Biol., 63, 247 254.
29. Gumkowski, F., Kaminski, G., Kaminski, M., Morrissey, L.W. and Auerbach, R. (1987) Heterogeneity of mouse vascular endothelium. Blood Vessels, 24, 11-23.
30. Bussolino, F., Camussi, G., Aglietta, M., Braquet, P., Bosia, A., Pescarmona, G., Sanavio, F., D'Urso, N. and Marchisio, P.C. (1987) Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J. Immunol., 139, 2439-2446.
31. Corada, M., Mariotti, M., Thurston, G. et al. (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl Acad. Sci. USA, 96, 9815-9820.
32. Grossi, M.P., Caputo, A., Rimessi, P., Chiccoli, L., Balboni, P.G. and Barbanti-Brodano, G. (1988) New BK virus episomal vector for complementary DNA expression in human cells. Arch. Virol., 102, 275-283.
33. Maraldi, N.M., Barbanti-Brodano, G., Portolani, M. and La Placa, M. (1975) Ultrastructural aspects of BK virus uptake and replication in human fibroblasts. J. Gen. Virol., 27, 71-80.
34. Portolani, M., Marzocchi, A., Barbanti-Brodano, G. and La Placa, M. (1974) Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J. Med. Microbiol., 7, 543-546.
35. Aaronson, S.A. and Todaro, G.J. (1970) Infectious SV40 and SV40 DNA: rapid fluorescent focus assay. Proc. Soc. Exp. Biol. Med., 134, 103-106.
36. Graham, F.L. and van der Eb, A.J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
37. Sambrook, J., Fritsch, E. and Maniatis, T. (1989) In Nolan,C. (ed.), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, Book 2.
38. Gebris, A.L., Pisano, M.M., Nugent, P. and Greene, R.M. (1994) Regulation of TGFb3 gene expression in embryonic palatal tissue. In Vitro Cell. Dev. Biol. Anim., 30A, 671-679.
39. Rigby, P.W.J., Dieeckman, M., Rhodes, C. and Berg, P. (1977) Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol., 113, 237-251.
40. Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P.M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119, 629-641.
41. Pintavom, P. and Ballermann, B.J. (1997) TGF-beta and the endothelium during immune injury. Kidney Int., 51, 1401-1412.
42. Yang, E.Y. and Moses, H.L. (1990) Transforming growth factor Β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell. Biol., 11, 731-741.
43. Postlethwaite, A.E., Keski-Oja, J., Moses, H.L. and Kang, A.H. (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med., 165, 251-256.
44. Hamilton, J.A., Piccoli, D.S., Leizer, T., Butler, D.M., Croatto, M. and Royston, A.K. (1991) Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts. Proc. Natl Acad. Sci. USA, 88, 7180-7184.
45. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V. and Kehrl, J.H. (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA, 83, 4167-4171.
46. Mustoe, T.A., Pierce, G.F., Thomason, A., Gramates, P., Sporn, M.B. and Deuel, T.F. (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science, 237, 1333-1336.
47. Clemens, M.J. (1991) Cytokines in health and disease. In Read,P. and Brown,T. (eds) Cytokines Medical Perspectives Series A. BIOS Scientific Publishers Limited, Oxford, UK, pp. 75-97.
48. Derynck, R., Sarrett, S.A., Chen, E.Y. and Goeddel, D.V. (1986) The murine transforming growth factor-beta precursor. J. Biol. Chem., 261, 4377-4379.
49. Folkman, J. and Hanahan, D. (1991) Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp., 22, 339-347.
50. Yang, R.C. and Wu, R. (1979) BK virus DNA sequence: extent of homology with simian virus 40 DNA. Proc. Natl Acad. Sci. USA, 76, 1179-1183.
51. Portolani, M., Barbanti-Brodano, G. and La Placa, M. (1975) Malignant transformation of hamster kidney cells in vitro by BK virus. J. Virol., 15, 420-422.
52. Tanaka, R., Koprowski, H. and Iwasaki, Y. (1976) Malignant transformation of hamster brain cells in vitro by human papovavirus BK. J. Natl Cancer Inst., 56, 671-673.
53. Portolani, M., Borgatti, M., Corallini, A., Cassai, E., Grossi, M.P., Barbanti-Brodano, G. and Possati, L. (1978) Stable transformation of mouse, rabbit and monkey cells and abortive transformation of human cells by BK virus, a human papovavirus. J. Gen. Virol., 38, 369-374.
54. Gualandi, F., Morelli, C., Pavan, V.J., Rimessi, P., Sensi, A., Bonfatti, A., Gruppioni, R., Possati, L., Stanbridge, E.J. and Barbanti-Brodano, G. (1994) Induction of senescence and control of tumorigenicity in BK virus transformed mouse cells by human chromosome 6. Genes Chrom. Cancer, 10, 77-84.
55. Asakura, S., Kato, H., Fujino, S., Konishi, T., Tezuka, N. and Mori, A. (1999) Role of transforming growth factor-beta1 and decorin in development of central fibrosis in pulmonary adenocarcinoma. Hum. Pathol., 30, 195-198.
56. Wenger, C., Ellenrieder, V., Alber, B. et al. (1999) Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene, 18, 1073-1080.
57. Orsatti, G., Hytiroglou, P., Thung, S.N., Ishak, K.G. and Paronetto, F. (1997) Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver, 17, 152-156.
58. Dickson, M.C., Martin, J.S., Cousins, F.M., Kulkarni, A.B., Karlsson, S. and Akhurst, R.J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development, 121, 1845-1854.
59. Li, D., Sorensen, L.K., Brooke, B.S., Umess, L.D., Davis, E.C., Taylor, D.G., Boak, B.B. and Wendel, D.P. (1999) Defective angiogenesis in mice lacking endoglin. Science, 284, 1534-1537.
60. Gohongi, T., Fukumura, D., Boucher, Y., Yun, C.O., Soff, G.A., Compton, C., Todoroki, T. and Jain, R.K. (1999) Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1. Nature Med., 5, 1203-1208.
61. Madri, J.A., Pratt, B.M. and Tucker, A.M. (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends on the composition and organization of the extracellular matrix. J. Cell. Biol., 106, 1375-1384.
62. Merwin, J.R., Newman, W., Beall, L.D., Tucker, A. and Madri, J.A. (1991) Vascular cells respond differentially to transforming growth factors be ta 1 and beta 2 in vitro. Am. J. Pathol., 138, 37-51.
63. Saksela, O., Moscatelli, D.M. and Rifkin, D.B. (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell. Biol., 105, 957-963.
64. Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P. and Birchmeier, W. (1987) Inhibitory action of transforming growth factor β on endothelial cells. Proc. Natl Acad. Sci. USA, 84, 5600-5604.
65. Qu, Z., Huang, X., Ahmadi, P., Stenberg, P., Liebler, J.M., Le, A.C., Planck, S.R. and Rosenbaum, J.T. (1998) Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int. Arch. Allergy Immunol., 115, 47-54.
66. Brogi, E., Wu, T., Namiki, A. and Isner, J.M. (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation, 90, 649-652.
67. Mandriota, S.J., Menoud, P.A. and Pepper, M.S. (1996) Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J. Biol. Chem., 271, 11500-11505.
68. Annes, J. (1989) A review of Kaposi's sarcoma. Adv. Cancer Res., 53 73-87.
69. Ito, N., Kawata, S., Tsushima, H., Tamura, S., Kiso, S., Takami, S., Igura, T., Monnden, M. and Matsuzawa, Y. (1997) Increased circulating transforming growth factor beta 1 in a patient with giant hepatic hemangioma: possible contribution to an impaired immune function. Hepatology, 25, 93-96.
70. Dillard, D.G., Cohen, C., Mullet, S., Del Gaudio, J., Reichman, O., Parrish, B., Rackley, D. and Gal, A. (2000) Immunolocalization of activated transforming growth factor beta 1 in juvenile nasopharyngeal angiofibroma. Arch. Otolaryngol. Head Neck Surg., 126, 723-725.
71. Uhr, J.W., Scheuermann, R.H., Street, N.E. and Vitetta, E.S. (1997) Cancer dormancy: opportunities for new therapeutic approaches. Nature Med., 3, 505-509.
72. Vaage, J (1992) Fibrosis in immune control of mammary tumor growth. Int. J. Cancer, 51, 325-328.
73. Vaage, J. and Harlos, J.P. (1991) Collagen production by macrophages in tumor encapsulation and dormancy. Br. J. Cancer, 63, 758-762.
74. Kondo, Y., Izumi, T., Yanagawa, T., Kanda, H., Katano, H. and Sata, T. (2000) Spontaneously regressed Kaposi's sarcoma and human herpesvirus 8 infection in a human immunodeficiency virus-negative patient. Pathol. Int., 50, 340-346.
75. Nagy, S., Gyulai, R., Kemeny, L., Szenohradszky, P. and Dobozy, A. (2000) Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immumosuppressive therapy. Transplantation, 69(10), 2230-2231.